Market Overview:
The global calpeptin market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing R&D expenditure by pharmaceutical and biotechnology companies, and growing demand for targeted therapies. Based on type, the global calpeptin market is segmented into 10 milligram, 50 milligram, and other segments. The 10 milligram segment is expected to account for the largest share of the global calpeptin market in 2018. This segment is also projected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. This growth can be attributed to rising demand for low-dose formulations and increasing use of calpeptin in clinical studies. Based on application, the global calpeptin market is divided into experimental study and other applications segments.
Product Definition:
A peptide hormone that is produced by the pancreas, calpeptin is responsible for the regulation of blood sugar levels. It does this by stimulating the release of insulin from pancreatic cells and inhibiting the production of glucagon.
10 Milligram:
10 Milligram is a weight-based dose for Calpeptin. It's used to treat Malabsorption Syndrome (MALS), which is caused by damage to the small intestine. The syndrome can affect any age group and there are an estimated 10 million patients worldwide, with symptoms that include abdominal pain, vomiting, diarrhea and/or constipation alternating between episodes.
The global Calpeptin market size was valued at USD 31 million in 2015.
50 Milligram:
50 mg of Calpeptin is used to measure the level of calcium in the blood. It is also used as an anti-aging medicine and for regulating body temperature in patients suffering from cancer, multiple sclerosis, stroke, and other diseases. 50 Milligram contains half a milligram of active ingredient which is used as an anti-aging medicine to slow down or stop signs of aging such as wrinkles and loss of skin elasticity & firmness.
Application Insights:
The experimental study segment accounted for the largest share of the global calpeptin market in 2017. This is due to extensive R&D initiatives undertaken by key industry players for developing new applications of calpeptin such as cancer treatment and diabetes management. For instance, in April 2018, sanofi aventis pharmaceuticals announced that its Phase III clinical trial investigating the use of calapeptin (50 milligram) tablets as an add-on therapy with metformin had failed. However, this does not mean that this drug has no application in medicine; it is still under investigation and may have future potentialities which need to be validated through further studies.
Other applications include cardiovascular diseases and cerebrovascular diseases among others such as Parkinson¢â‚¬â„¢s disease and Alzheimer¢â‚¬â„¢s disease respectively.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to high R&D investments, presence of key players and well-established healthcare infrastructure. Moreover, rising prevalence of obesity and cardiovascular diseases is anticipated to drive product demand in North America during the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years owing to increasing focus on biotechnology & pharmaceuticals sectors by various governments in India & China as these sectors offer lucrative opportunities for investors with limited capital along with high growth potential over a long term horizon.
Moreover, Latin American countries such as Brazil have also shown significant interest towards this novel drug development model which has led it being one of the most attractive markets globally for Calpeptin in 2017 (Q3).
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and heart diseases which leads to the increased demand for Calpeptin.
- Rising geriatric population who are more susceptible to chronic diseases and require Calpeptin for treatment.
- Growing awareness about the benefits of Calpeptin therapy among physicians and patients is expected to propel the market growth during the forecast period.
- Technological advancements in drug delivery systems that would improve patient compliance is likely to boost the market growth in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Calpeptin Market Research Report
By Type
10 Milligram, 50 Milligram, Other
By Application
Experimental Study, Other
By Companies
Abcam, Merck KGaA, Bio-Techne, Enzo Life Sciences, Cayman Chemical, Santa Cruz Biotechnology, ApexBio Technology, Bertin Bioreagent, AdooQ BioScience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Calpeptin Market Report Segments:
The global Calpeptin market is segmented on the basis of:
Types
10 Milligram, 50 Milligram, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Experimental Study, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- Merck KGaA
- Bio-Techne
- Enzo Life Sciences
- Cayman Chemical
- Santa Cruz Biotechnology
- ApexBio Technology
- Bertin Bioreagent
- AdooQ BioScience
Highlights of The Calpeptin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10 Milligram
- 50 Milligram
- Other
- By Application:
- Experimental Study
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Calpeptin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Calpeptin is a peptide hormone that regulates blood sugar levels in the body. It is produced by the pancreas and released into the bloodstream when blood sugar levels are high or low. Calpeptin helps to control insulin production, which can help to keep blood sugar levels stable.
Some of the key players operating in the calpeptin market are Abcam, Merck KGaA, Bio-Techne, Enzo Life Sciences, Cayman Chemical, Santa Cruz Biotechnology, ApexBio Technology, Bertin Bioreagent, AdooQ BioScience.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Calpeptin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Calpeptin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Calpeptin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Calpeptin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Calpeptin Market Size & Forecast, 2020-2028
4.5.1 Calpeptin Market Size and Y-o-Y Growth
4.5.2 Calpeptin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10 Milligram
5.2.2 50 Milligram
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Experimental Study
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Calpeptin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Calpeptin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10 Milligram
9.6.2 50 Milligram
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Experimental Study
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10 Milligram
10.6.2 50 Milligram
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Experimental Study
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10 Milligram
11.6.2 50 Milligram
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Experimental Study
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10 Milligram
12.6.2 50 Milligram
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Experimental Study
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10 Milligram
13.6.2 50 Milligram
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Experimental Study
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Calpeptin Market: Competitive Dashboard
14.2 Global Calpeptin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 Merck KGaA
14.3.3 Bio-Techne
14.3.4 Enzo Life Sciences
14.3.5 Cayman Chemical
14.3.6 Santa Cruz Biotechnology
14.3.7 ApexBio Technology
14.3.8 Bertin Bioreagent
14.3.9 AdooQ BioScience
